News & Updates
Filter by Specialty:
Exercise-based rehab improves exercise capacity in long COVID patients
Results from the PHOSP-R* trial show that exercise-based rehabilitation (EBR) improves short-term exercise capacity in individuals with post-COVID syndrome (long COVID) following an acute hospitalization.
Exercise-based rehab improves exercise capacity in long COVID patients
21 Jul 2025
Subcutaneous on par with IV pembrolizumab for NSCLC
Pembrolizumab administered subcutaneously (SC) is noninferior to the intravenous (IV) strategy in terms of overall exposure and trough concentrations, with similar efficacy and consistent safety profiles in patients with treatment-naive metastatic nonsmall cell lung cancer (NSCLC), reports a study.
Subcutaneous on par with IV pembrolizumab for NSCLC
17 Jul 2025
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
Nerandomilast slows IPF progression in patients already on antifibrotic therapy
The novel oral PDE4B* inhibitor nerandomilast slows the progression of idiopathic pulmonary fibrosis (IPF) in patients receiving antifibrotic treatment, as shown in the phase III FIBRONEER-IPF trial.
